{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:28:00Z","timestamp":1790306880462,"version":"4.1.0"},"reference-count":25,"publisher":"American Society for Clinical Investigation","issue":"13","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,3]]},"DOI":"10.1172\/jci171310","type":"journal-article","created":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T18:01:11Z","timestamp":1688320871000},"source":"Crossref","is-referenced-by-count":8,"title":["Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphoma"],"prefix":"10.1172","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-882X","authenticated-orcid":false,"given":"Adam Yuh","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-7064","authenticated-orcid":false,"given":"Leo I.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0635-3"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0515-x"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.06.006"},{"issue":"13","key":"B4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166070","article-title":"Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma","volume":"133","author":"Apollonio","year":"2023","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.037"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00335-8"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900496"},{"issue":"1","key":"B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000784"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00766"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000847"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007400"},{"key":"B14","unstructured":"Herrera AF, et al. SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL). Paper presented at: 2023 ASCO Annual Meeting II; June 2\u20136, 2023; Chicago, Illinois, USA. https:\/\/meetings.asco.org\/2023-asco-annual-meeting\/15047?presentation=219808#219808. Accessed June 20, 2023"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00662-6"},{"issue":"19","key":"B18","first-page":"2307","article-title":"5-year follow-up supports curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1)","volume":"141","author":"Neelapu","year":"2023","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.08.011"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01916-x"},{"issue":"1","key":"B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-023-00373-7","article-title":"Current advances and challenges in CAR T-cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment","volume":"12","author":"Yan","year":"2023","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"B23","first-page":"1","article-title":"A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.04.004"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.635371"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/171310\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T07:37:25Z","timestamp":1702712245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/171310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":25,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7,3]]},"published-print":{"date-parts":[[2023,7,3]]}},"alternative-id":["10.1172\/JCI171310"],"URL":"https:\/\/doi.org\/10.1172\/jci171310","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"article-number":"e171310"}}